DAVIS, Calif., Dec. 7, 2017 /PRNewswire/ -- Cedaron Medical announced today that it is now an authorized vendor for the American Heart Association's premier registry for acute myocardial infarction, the Get With The Guidelines®-Coronary Artery Disease (GWTG-CAD) registry.
For more than 20 years, Cedaron's one focus has been ensuring that busy medical professionals can manage their patient data and get crucial analytics with minimal time and labor. To that end, Cedaron's CardiacCare software acts as a bridge between cardiology caregivers and numerous registries, and a built-in program allows individual clients to evaluate their own patient outcomes.
With CardiacCare, caregivers have a single intelligent platform that saves time, reduces costs and reduces errors. Cedaron has now added the American Heart Association's GWTG-CAD registry to this suite.
"We're excited to give our clients the opportunity to report to the American Heart Association's registry," said Cedaron CEO Karen Bond, "because we have seen vast improvements in patient outcomes as more data from registries has become available for study."
Every year, about 790,000 Americans have a heart attack, or myocardial infarction, because a portion of their hearts do not receive the needed blood flow. Clinical data registries make evidence-based medicine possible by measuring patient outcomes from dozens of institutions. They allow assessment of quality of care, efficacy of treatments, comparable performance and more.
"At Cedaron, we think access to data is crucial," said Cedaron chief scientist Malcolm Bond, "so we include Cento Analytics software in the CardiacCare suite. Each of our clients can study the patient data they send to multiple registries. That way, they can quickly see any issues and make improvements."
About Cedaron Medical:
Founded in 1990, Cedaron Medical works relentlessly to develop software that provides the evidence-based data that medical professionals need to improve patient outcomes. The company launched with the idea of creating a robotics product to improve outcomes in hand therapy and hand surgery. That concept won a NASA Small Business Innovation Research Grant and still fuels the company's vision to greatly improve documentation in the specialties of rehabilitation, cardiology and workers compensation. Cedaron, still run by founders Karen Bond, Dr. Malcolm Bond and Gary Engle, works with a global list of clients ranging from large healthcare institutions to solo practices.
CONTACT: Karen Bond
Chief Executive Officer
SOURCE Cedaron Medical Inc.